FIELD: veterinary medicine. SUBSTANCE: the suggested vaccine contains as an antigen a 10-15%-hepatic suspension of rabbits died after infection by virulent viral strain of viral hemorrhagic disease in rabbits isolated out of local epizootic focus upon physiological solution (pH 7.2), theotropin, alumopotash alum at the following ratio of components, weight%: rabbits' hepatic suspension 98.1-98.6, theotropin 0.3-0.4, alumopotash alum 1.0-1.5. The suggested vaccine is of high immunogenicity and safe. EFFECT: higher efficiency. 5 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING VACCINE AGAINST VIRAL HEMORRHAGIC DISEASE IN RABBITS | 2002 |
|
RU2231365C1 |
| METHOD OF MANUFACTURING VACCINE, ASSOCIATED AGAINST PSEUDOMONOSIS AND VIRAL RABBIT HAEMORRHAGIC DISEASE | 2013 |
|
RU2553557C2 |
| METHOD TO MANUFACTURE VACCINE ASSOCIATED AGAINST STREPTOCOCCOSIS AND VIRUS HAEMORRHAGIC DISEASE OF RABBITS | 2010 |
|
RU2429880C1 |
| METHOD FOR PRODUCING ASSOCIATED COLIBACILLOSIS, STREPTOCOCCOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2010 |
|
RU2443774C1 |
| METHOD FOR PRODUCING ASSOCIATED SALMONELLOSIS, ESCHERICHIOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2012 |
|
RU2496518C1 |
| ASSOCIATED STREPTOCOCCOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2010 |
|
RU2429879C1 |
| ASSOCIATED SALMONELLOSIS, ESCHERICHIOSIS AND RABBIT VIRAL HAEMORRHAGIC DISEASE VACCINE | 2012 |
|
RU2510839C2 |
| ASSOCIATED COLIBACILLOSIS, STREPTOCOCCOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2010 |
|
RU2443775C1 |
| ASSOCIATED PSEUDOMONOSIS AND RABBIT VIRAL HAEMORRHAGIC DISEASE VACCINE | 2013 |
|
RU2531054C1 |
| STRAIN "SHEVCHENKO-2014" OF RABBIT HEMORRHAGIC DISEASE VIRUS FOR PREPARING VACCINES, DIAGNOSTIC AND THERAPEUTIC PREPARATIONS | 2015 |
|
RU2631925C2 |
